Takashi Matsumoto

7PUBLICATIONS
18CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Dec 10, 2025
A case of dramatic response to pembrolizumab monotherapy in dMMR unresectable colorectal cancer diagnosed following abdominal hemorrhage due to segmental arterial mediolysis.

Takashi Matsumoto, Kohei Yamashita, Shinsei Yumoto

|Nov 25, 2025
High γ-H2AX Predicts Clinical Benefit From Platinum-Based Chemotherapy (mFOLFIRINOX) at Recurrence After Pancreatic Cancer Resection.

Takashi Matsumoto, Zhao Liu, Kosuke Kanemitsu

|Nov 07, 2025
Prognostic Impact of Hepatectomy Versus Radiofrequency Ablation for Non-Small Hepatocellular Carcinoma (2-3 cm): A Case-Matched Study.

Yuki Kitano, Hiromitsu Hayashi, Takumi Tanizaki

|May 28, 2025
Integrated hepatic ferroptosis gene signature dictates pathogenic features of ferroptosis.

|Oct 22, 2024
Prognostic impact of aspirin in patients with hepatocellular carcinoma after liver resection: propensity-score-matched analysis.

Takashi Matsumoto, Yuki Kitano, Katsunori Imai

|Jan 27, 2022
Clinical significance of preoperative inflammation-based score for the prognosis of patients with hepatocellular carcinoma who underwent hepatectomy.

Takashi Matsumoto, Yuki Kitano, Katsunori Imai

Pageof 2

Frequent Collaborators

3 joint publications

Hiromitsu Hayashi

3 joint publications

Yuki Kitano

2 joint publications

Masaaki Iwatsuki

2 joint publications

Kosuke Mima